Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹3,401.90
45.90 (1.37%)
Medium VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹7.83K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
24.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹3,054+11.4%
52W High₹6,048-43.8%
Current Price
₹3,401.90
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹2,721.52
Upper Circuit₹4,082.28
Reference Price
₹3,401.90
Investment Checklist
Rounding Bottom on 1D — target ₹3766.4
Cup and Handle on 1D — target ₹3758.5
Volume divergence: Bearish (price up, volume down)
Unusual volume detected (2.6x average) — institutional activity likely
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
3367.72
EMA50
3350.63
EMA200
3961.06
Price Action
CONSOLIDATION
NEUTRAL
Higher Highs5
Higher Lows4
Lower Highs4
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹3609.00
₹3983.73
₹4054.50
₹4144.40
₹4241.00
Support (Below)
₹3250.00
₹3160.00
₹3085.20
₹3054.00
Volume Analysis
TrendDECREASING
Change-17.50%
Unusual Volume
Yes (2.58x avg)
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹3367.88
3% Risk₹3299.84
5% Risk₹3231.80
7% Risk (Custom)
₹3163.77Technical Levels
1x ATR (Volatility)₹3325.03
2x ATR (Swing)₹3248.16
3x ATR (Trend)₹3171.29
Immediate Support₹3250.00
Moving Averages
EMA 9 (Short-term)₹3401.25
EMA 20 (Medium-term)₹3367.72
EMA 50 (Trend)₹3350.63
Financials
Financial Analysis
| Metric | Sep '24 | Dec '24 | Mar '25 | Jun '25 |
|---|---|---|---|---|
| Revenue | ₹524 Cr | ₹490.7 Cr | ₹535.9 Cr | ₹406.3 Cr |
| Net Profit | ₹82.2 Cr | ₹91.3 Cr | ₹119.5 Cr | ₹69.5 Cr |
| EPS | ₹35.69 | — | ₹51.89 | ₹30.18 |
| Operating Profit | ₹122 Cr | ₹132.2 Cr | ₹175.2 Cr | ₹103.6 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Sanofi India Limited | ₹3,401.90 | +1.37% | 25.0 | ₹7.83K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 22 Apr 2026 | Dividend - Rs 48 Per Share | DIVIDEND |
| 07 Nov 2025 | Interim Dividend - Rs 75 Per Share | INTERIM_DIVIDEND |
| 25 Apr 2025 | Dividend - Rs 117 Per Share | DIVIDEND |
| 13 Jun 2024 | Demerger | DEMERGER |
| 03 May 2024 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SANOFI
View AllNEWS
positive
Business Standard - Markets 26d ago
Sanofi India jumps after Nippon India MF adds stake
Shares of Sanofi India surged 5.58% to Rs 3,295 after a bulk deal involving the company's shares was executed on the BSE.
BSESANOFISNXT30BEESFinancial ServicesHealthcare
neutral
Google News - India Markets 46d ago
Sanofi Consumer Healthcare India appoints PwC as statutory auditor for five-year term - scanx.trade
Sanofi Consumer Healthcare India appoints PwC as statutory auditor for five-year termscanx.trade
CONSUMERHCGHCG-REHEALTHCARESANOFISANOFICONRFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 62d ago
Cigniti Tech exits Nifty indices following amalgamation with Coforge
As part of the changes, Cigniti Technologies will be removed from the Nifty Microcap 250 index and replaced by Sanofi Consumer Healthcare India.
BANKIETFCIGNITITECCOFORGECONSUMERELM250GROWWSC250HCGHCG-REHDFCSML250HEALTHADDHEALTHAXISHEALTHCAREHEALTHIETFHEALTHYMOSMALL250PVTBANIETFSANOFISANOFICONRSMALL250SMALLADDSMALLCAPTECHZTECHFinancial ServicesHealthcare